Sunshine Biopharma
SBFM
8 hedge funds and large institutions have $746K invested in Sunshine Biopharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
100% more funds holding
Funds holding: 4 → 8 (+4)
80% more capital invested
Capital invested by funds: $415K → $746K (+$331K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$330K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$51.2K |
| 3 |
Renaissance Technologies
New York
|
+$17.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5.69K |
| 5 |
VF
Virtu Financial
New York
|
+$5.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$5K |
| 2 |
NECFA
New England Capital Financial Advisors
Meriden,
Connecticut
|
-$160 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $578K | +$330K | +58 | +118% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $77.7K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $50.3K | +$51.2K | +9 | New |
|
|
4
Renaissance Technologies
New York
| $18K | +$17.1K | +3 | New |
|
|
VF
5
Virtu Financial
New York
| $6K | +$5.69K | +1 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $5.48K | – | – | – |
|
|
XT
7
XTX Topco
George Town,
Cayman Islands
| $4.75K | +$5.69K | +1 | New |
|
|
8
Bank of America
Charlotte,
North Carolina
| $2.71K | +$5.69K | +1 | New |
|
9
National Bank of Canada
Montreal,
Quebec, Canada
| $1.63K | – | – | – |
|
10
UBS Group
Zurich,
Switzerland
| $598 | – | – | – |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $220 | – | – | – |
|
|
MSG
12
Main Street Group
Glen Allen,
Virginia
| $60 | – | – | – |
|
|
FDCDDQ
13
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $21 | – | – | – |
|
|
HF
14
HRT Financial
New York
| – | -$5K | -1 | Closed |
|
|
NECFA
15
New England Capital Financial Advisors
Meriden,
Connecticut
| – | -$160 | – | – |
|
SBFM Hedge Fund Activity: Q4 2023 in Review
8 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q4 2023, worth a combined $746K — up 80% from $415K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SBFM positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, adding an estimated $330K. The largest seller was HRT Financial, exiting entirely with an estimated $5K sold.
- 8 institutional investors held Sunshine Biopharma (SBFM) as of Q4 2023, up from 4 in Q3 2023.
- Funds reported $746K of Sunshine Biopharma stock for Q4 2023, up 80% quarter-over-quarter.
- 5 funds opened new Sunshine Biopharma positions in Q4 2023 and 1 closed out, a net change of +4 holders.
- The largest Sunshine Biopharma buyer in Q4 2023 was Armistice Capital, an estimated $330K added.
- The largest Sunshine Biopharma seller in Q4 2023 was HRT Financial, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2023.